** Shares of medical device maker Procept BioRobotics PRCT.O rise 2.3% to $57 premarket
** Company raises its annual revenue forecast to $323 million, compared with previous forecast of $320 million and analysts' estimates of $321.96 million, according to data compiled by LSEG
** Company reports Q1 revenue of $69.2 million, up 55% year-over-year, beating analysts' estimates of $65.7 million
** PRCT posts Q1 loss of 45 cents per share, smaller than expectations of 49 cents per share
** As of last close, PRCT has fallen 30.8% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。